Deep Track Capital, LP 13D and 13G filings for Immunovant, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-26 4:09 pm Purchase |
2025-03-19 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 9,500,000 5.590% |
8,500,000 (+850.00%) |
Filing |
| 2024-02-14 08:47 am Sale |
2023-12-31 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 1,000,000 0.690% |
-8,710,000 (-89.70%) |
Filing |
| 2023-02-14 08:37 am Purchase |
2022-12-31 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 9,710,000 7.520% |
2,929,173 (+43.20%) |
Filing |
| 2022-02-11 5:11 pm Purchase |
2022-02-04 | 13G | Immunovant, Inc. IMVT |
Deep Track Capital, LP | 6,780,827 5.830% |
6,780,827 (New Position) |
Filing |